RenovoRx, Inc. (RNXT)
NASDAQ: RNXT · Real-Time Price · USD
1.120
-0.050 (-4.27%)
At close: Oct 17, 2025, 4:00 PM EDT
1.160
+0.040 (3.57%)
After-hours: Oct 17, 2025, 7:53 PM EDT
RenovoRx Market Cap
RenovoRx has a market cap or net worth of $41.04 million as of October 17, 2025. Its market cap has increased by 70.26% in one year.
Market Cap
41.04M
Enterprise Value
28.99M
1-Year Change
70.26%
Ranking
Category
Stock Price
$1.12
Market Cap Chart
Since the IPO on August 26, 2021, RenovoRx's market cap has decreased from $68.64M to $41.04M, a decrease of -40.21%. That is a compound annual growth rate of -11.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 17, 2025 | 41.04M | 32.56% |
| Dec 31, 2024 | 30.96M | 26.43% |
| Dec 29, 2023 | 24.49M | 14.54% |
| Dec 30, 2022 | 21.38M | -50.41% |
| Dec 31, 2021 | 43.12M | -37.19% |
| Aug 26, 2021 | 68.64M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 741.71B |
| Johnson & Johnson | 463.65B |
| AbbVie | 400.23B |
| UnitedHealth Group | 325.00B |
| AstraZeneca | 262.65B |
| Novartis AG | 252.43B |
| Novo Nordisk | 251.88B |
| Abbott Laboratories | 224.26B |